Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06643299 · ClinicalTrials.gov registry record · Phase 2

Probiotic Use for Recovery Enhancement From Long COVID-19

A Phase 2 study of Post-Acute COVID-19 Syndrome, sponsored by Rush University Medical Center.

Active
Registry status
Phase 2
Development phase
180
Enrollment target
1
Study location

NCT06643299 is a Phase 2 study of Post-Acute COVID-19 Syndrome that is active but no longer recruiting, run by Rush University Medical Center. The registered enrollment target is 180 participants, below the 831-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06643299, a Phase 2 study of Post-Acute COVID-19 Syndrome, is active but no longer recruiting, sponsored by Rush University Medical Center.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if probiotics can improve symptoms and quality of life in participants with Long COVID.

Conditions Studied

Post-Acute COVID-19 Syndrome

Interventions

  • OTHER Placebo
  • DRUG Probiotic Agent

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2025-05-13
Est. Completion 2026-07
Phase Phase 2

Sponsor

Rush University Medical Center

320 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06643299

The ClinicalTrials.gov registry entry for NCT06643299 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 831-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (78% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-Acute COVID-19 Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06643299 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06643299 about?

NCT06643299 is a clinical study titled "Probiotic Use for Recovery Enhancement From Long COVID-19". The goal of this clinical trial is to learn if probiotics can improve symptoms and quality of life in participants with Long COVID.

What is the current status of trial NCT06643299?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2025-05-13. Estimated completion is 2026-07.

What conditions does trial NCT06643299 study?

This clinical trial studies the following conditions: Post-Acute COVID-19 Syndrome.

What interventions are being tested in trial NCT06643299?

The interventions under investigation include: Placebo (OTHER), Probiotic Agent (DRUG).

Who is sponsoring clinical trial NCT06643299?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06643299 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Post-Acute COVID-19 Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Post-Acute COVID-19 Syndrome

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.